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1. Introduction 
In recent years, metabolomics has surfaced as an 
innovative research strategy in human metabolism, whereby 
selection of the biological matrix and its inherent metabolome 
is of crucial importance. However, focusing on a single matrix 
may imply that relevant molecules of complementary 
physiological pathways, covered by other matrices, are 
missed. The combination of different matrices encloses the 
potential to reveal more significant results and interesting 
correlations in comparison to single-matrix analyses [1]. 
 
2. Approach 
This study presents a unique multi-matrix platform for 
the concurrent polar metabolic fingerprinting of feces, plasma 
and urine, applying ultra-high performance liquid-
chromatography coupled to hybrid quadrupole-Orbitrap high-
resolution mass spectrometry. All three fingerprinting 
approaches were proven ‘fit-for-purpose’ through extensive 
validation in a targeted as well as an untargeted fashion [1, 2].  
To demonstrate the potential of the platform, fecal, urine 
and plasma samples (collected within a single day) from ten 
healthy volunteers were subjected to metabolic fingerprinting 
to discriminate according to metabolic state. As no specific 
disease conditions or age differences were present among the 
participants, it was opted to determine the metabolic 
discrepancies between males and females. 
 
3. Results and Discussion 
For targeted and untargeted validation of all three 
matrices, linearity (coefficients of determination R2 ≥ 0.99 or 
0.90, respectively), recovery (between 70 and 120%) and 
precision (coefficients of variance ≤ 15% or 30%, 
respectively) were assessed. The excellent validation results 
indicated that the analytical methods were ‘fit-for-purpose’ 
and suitable to accurately map the metabolome, along diverse 
chemical classes. 
The effectivity of the platform was demonstrated by 
subjecting fecal, urine and plasma samples from ten healthy 
volunteers to metabolic profiling and fingerprinting, yielding 
respectively 9672, 9647 and 6122 components, with a 
substantial overlap of the plasma metabolome with the fecal 
(69.48%) and urinary metabolome (76.79%) (Figure 1). The 
fecal metabolome displayed the highest number of 
components, followed by urine and plasma. Subsequent 
OPLS-DA modelling suggested that plasma and feces are 
equally suited to assess gender-dependent metabolic 
differences. As such, due to its discriminative abilities, non-
invasive nature of sample collection and excellent coverage, 
feces proved itself as an excellent alternative to plasma.  
 
Figure 1. PCA-X score plot and Venn diagram of urine, fecal 
and plasma samples 
To evaluate the added value of a multi-matrix over a 
single-matrix platform, the fingerprinting abilities of both 
platforms were compared, revealing an increased number of 
recovered metabolites and improved model predictivity for 
the multi-matrix approach. As such, it has the unprecedented 
potential to reveal more significant results, including the 
discovery of biomarkers and unraveling of mechanistic 
information. The latter was demonstrated using targeted 
profiling, which revealed noticeable differences (i.e. min. 
30% difference) between male and female participants in the 
beta-alanine pathway (Figure 2). In fecal samples from men, 
higher concentrations of metabolites, associated with the 
beta-alanine pathway, were observed, while these metabolites 
were up-regulated in plasma samples from women, which 
may relate to the menstrual cycle. The increased plasma 
concentration was then reflected in higher levels of uracil and 
pantothenic acid in the urine of women [1]. 
 
Figure 2. Noticeable changes in the beta-alanine pathway. 
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